Medi Bomb #2 by Bomb Seeds: A Comprehensive Strain Guide

Overview

Medi Bomb #2 is a mostly sativa cultivar developed by Bomb Seeds, a breeder known for combining robust yields with reliable potency and vigor. Positioned as a medical-forward selection in their catalog, this strain emphasizes clear-headed effects and functional energy while maintaining approachable, balanced potency. For growers, it offers a sativa frame that still fits well in controlled spaces, especially when trained.

As a sativa-leaning hybrid, Medi Bomb #2 tends to showcase uplifting mental effects with a calm physical baseline, distinguishing it from heavier indica-dominant medical selections. While formal, peer-reviewed datasets specific to this cultivar remain limited in public repositories, seedbank-listed metrics and community reports place it in a sweet spot for users who want focus without racing anxiety. In comparative terms, it aims to deliver daytime usability with medical viability rather than sheer knockout power.

Bomb Seeds has long marketed strains with practical, grower-friendly architecture and predictable flowering windows, and Medi Bomb #2 follows that blueprint. The result is a cultivar that prioritizes consistent structure, straightforward feeding, and a flowering time typical of a refined sativa dominant hybrid. For patients and home cultivators alike, it stands out as a strain that is forgiving in the garden and versatile in the jar.

Across dispensary menus and private gardens, sativa-leaning medical strains remain popular for pain management, motivation, and mood support without heavy sedation. Medi Bomb #2 aligns with that demand, offering accessible potency, a terpene profile that often trends toward spicy-citrus tones, and yields that keep growers engaged. When dialed in, it produces a clean, aromatic flower that cures well and holds its quality in storage with proper handling.

History and Breeding Origins

Bomb Seeds, established in the late 2000s, earned a reputation for stable, high-yielding modern hybrids that translate well from seed to harvest. Their naming convention often highlights a purposeful design—big resin, manageable height, and predictable windows—and Medi Bomb #2 was created to satisfy medical users who prefer a sativa-led experience. The Medi Bomb line in general emphasizes ease of use and consistent chemistry, marking it out from ultra-high-THC novelty crosses.

While Bomb Seeds has not publicly disclosed the full pedigree in minute detail, the brand's catalog suggests a breeding strategy that cross-selects for vigor, resistance, and terpene-forward expression. In this system, a sativa-leaning backbone is refined for manageable internodes and responsive lateral branching. The result is a plant that behaves more politely than a classic tropical sativa while still showing that long-limbed lift.

The development arc for Medi Bomb #2 reflects a broader industry trend—crafting sativa-dominant options that do not require 12–14 weeks to finish. Many modern sativa hybrids now complete in roughly 9–11 weeks, a window that keeps production cycles viable while allowing for full terpene maturation. Medi Bomb #2 consistently falls within that range, making it attractive for commercial operators who need turns per year.

Positioned within Bomb Seeds’ portfolio, Medi Bomb #2 complements indica-forward lines like Kush Bomb and Ice Bomb by supplying a counterpart that’s clear, energetic, and daytime-friendly. It also rounds out the brand’s medical offerings by providing lighter body effects combined with focus and mood support. That balance is the core of its identity and the reason the strain endures across different markets.

Genetic Lineage and Heritage

The breeder lists Medi Bomb #2 as predominantly sativa in its heritage, and the plant exhibits phenotypic traits consistent with that classification. Expect longer internodal spacing compared with indica-dominant lines, an elongating canopy during the stretch, and narrower leaflets with a higher leaf-to-blade count. Even so, the hybridization keeps the architecture more compact than pure equatorial types.

While the full genetic recipe is kept proprietary, the expression suggests contributors with citrus-spice terpenes, higher limonene and caryophyllene probabilities, and a resin-forward floral character. Bomb Seeds often selects parents known for yield and vigor, which can include long-standing sativa hybrids optimized for indoor performance. This typically results in plants that double in height after the flip rather than tripling.

In practice, Medi Bomb #2 grows much like other modern sativa-leaning hybrids designed for tents and rooms—stretchy but controllable, top-friendly, and highly responsive to SCROG. The genetic intent appears to be a daytime functional chemotype rather than a super-sedative phenotype. For growers, this means planning for vertical space without fearing runaway height.

Compared with famously potent, THC-heavy modern strains such as Jealousy—which reviewers note can test in the high 20% THC range—Medi Bomb #2 rides closer to balanced potency with greater emphasis on usability. This orientation suits medical and wellness-use cases that prioritize relief without impairment. Many growers appreciate that balance because it broadens the audience for the final product.

Appearance and Morphology

Medi Bomb #2 typically develops medium-tall frames with elongated spears and foxtail-leaning clusters if light intensity and heat are pushed late in flower. Buds often present as conical to spear-shaped, with calyx-stacking that intensifies from week 5 onward. Under good environmental control, the plant fills out into tight, moderately dense colas rather than airy sativa wisps.

Coloration tends toward lime to mid-green with amber to orange pistils that can turn copper by harvest. Trichome coverage is strong for a medical-forward cultivar, leaving a frosted look that intensifies during the final 14–21 days. In colder late-flower conditions (16–18°C nights), some plants may exhibit faint lavender hues in the sugar leaves, though this is cut-dependent.

Expect a 1.5–2.0x stretch after the flip, with internodes that respond well to topping and lateral training to fill a screen. Side branches can rival the main cola if topped twice and arranged in a 6–10 node SCROG grid. Plant height indoors typically lands in the 90–140 cm range without aggressive height control.

Fan leaves are narrower with defined serrations and a glossy, mid-green surface when nutrition is balanced. If nitrogen is too high in early flower, leaf blades can broaden and slow flower formation. Keeping a leaner N profile and emphasizing potassium and calcium in mid-to-late bloom preserves the cultivar’s sativa-forward morphology and resin focus.

Aroma and Bouquet

Aromatically, Medi Bomb #2 usually leans into zesty citrus, sweet herb, and pepper-spice notes powered by limonene and caryophyllene. Early flower may smell green and herbal, shifting to a brighter citrus-peel character by week 6–7 as monoterpenes peak. Late flower often adds a subtle pine or green tea nuance that cleans up the finish.

When properly cured, the nose opens with lemon-orange brightness layered over soft floral sweetness and a light pepper tickle. Break a nug and expect a stronger herbal-citrus push followed by dry clove or cinnamon in some phenotypes. In jars, the bouquet expands dramatically in the first two weeks of cure and then stabilizes.

Like many sativa-dominant hybrids, sun-grown examples can display more complex aromas, a trend supported by outdoor quality reports and cultivation analysis. Industry write-ups on outdoor-grown cannabis note that full-season light and diurnal temperature swings can deepen terpene expression and nuance. Growers who finish this cultivar outdoors in mild-to-warm climates often report a fuller, more persistent citrus-spice aroma compared with sealed indoor runs.

Total terpene content for comparable sativa hybrids often ranges from 1.5–3.0% by weight in lab tests, depending on cultivation methods and post-harvest handling. Medi Bomb #2 tends to sit comfortably within that band when grown and dried carefully. Maintaining a slow dry at 60°F/60% RH for 10–14 days helps retain the delicate citrus top notes.

Flavor Profile

The flavor typically mirrors the aroma: citrus-forward with sweet herbs and a gentle pepper edge on the exhale. Vaporization at lower temperatures (175–185°C) emphasizes lemon-lime brightness and a delicate floral thread. Combustion adds mild spice and a faint woody echo, particularly in phenotypes richer in caryophyllene and humulene.

On fresh-cured flower, the initial draw can feel effervescent and clean, with a clinging citrus zest that hangs on the palate. As the bowl progresses, sweet greenery and light pepper develop without becoming harsh. When properly flushed and cured, the finish is crisp, leaving a lingering herbal-citrus sweetness.

Flavor stability improves significantly with tight environmental controls during late flower and a patient dry. Avoiding overdry conditions below 50% RH prevents the loss of high-volatility monoterpenes that carry the citrus. Water activity between 0.55 and 0.62 post-cure preserves flavor and limits microbial risk.

Compared to dessert-leaning strains like Apple Fritter—known for giggly, tingly effects and pastry-sweet profiles—Medi Bomb #2 skews fresher and zestier. Its spice-citrus spectrum resonates more with classic daytime sativas than bakery terps. That makes it a good pivot for users who want bright, clean flavors over confectionary notes.

Cannabinoid Profile and Potency

Seedbank and community reports place Medi Bomb #2’s THC in the mid-teens to low-20s, with many cuts clustering around 16–21% THC under standard conditions. While ultra-high-THC cultivars can exceed 28% THC in optimal scenarios, the aim here is balanced potency and clarity rather than sheer intensity. The cannabinoid profile often includes trace to modest CBD in certain phenotypes, though most batches are THC-dominant.

Total cannabinoids frequently land between 18–25% when grown skillfully, a range consistent with modern sativa hybrids optimized for yield and function. Growers working under high PPFD and dialed nutrition may see the upper end of that band with careful harvesting. Overripe harvests can show slightly higher measured THC due to continued cannabinoid development but may lose desired terpenes.

For context, popular heavy-hitters like Jealousy can test in the high 20s, but strains in this potency class are not always ideal for daytime medical use. Medi Bomb #2’s mid-range potency is deliberate and often more forgiving for newer patients titrating dose. It is common to find daily-use patients preferring chemotypes in the 15–20% THC range for repeatable relief without cognitive fog.

Minor cannabinoids such as CBG and CBC typically appear in trace amounts (<1%) in many modern hybrids, and Medi Bomb #2 follows that pattern. If you require a specific ratio—such as higher CBD for anxiety—verify certificates of analysis batch by batch. The underlying chemotype remains primarily THC-driven, with terpenes playing a major role in perceived effect.

Terpene Profile and Chemistry

While batch-specific lab data for Medi Bomb #2 are not broadly published, analogous sativa-dominant hybrids commonly show a terpene stack led by limonene, beta-caryophyllene, and myrcene. Typical ranges can look like limonene 0.3–0.8%, caryophyllene 0.2–0.5%, myrcene 0.3–0.7%, with supporting roles from humulene, linalool, ocimene, and terpinolene. Total terpenes often reach 1.5–3.0% by weight in well-grown, carefully dried flowers.

Caryophyllene deserves special mention because it uniquely binds to CB1/CB2 receptors as a dietary cannabinoid, and strains dominated by it have been associated with anti-inflammatory potential. Industry sources note cultivars like Zoap frequently express abundant caryophyllene alongside limonene and humulene, and Medi Bomb #2’s aroma suggests a similar, though not identical, pattern. This spicy-terp backbone contributes to the pepper-warmth on the finish and may nudge the body feel toward soothing without sedation.

Limonene likely drives the bright citrus top notes and may contribute to mood-elevating perceptions when combined with THC. Myrcene, often cited for its musky-sweet profile, can round out the herbal layer and modulate the onset feel, particularly when concentrations rise above 0.5%. Humulene, present as a secondary terpene, can add a dry, woody spice and has been explored for potential appetite-modulating effects in preclinical contexts.

Because terpenes are volatile and sensitive to heat and oxygen, cultivation and post-harvest practices heavily influence the final profile. Keeping drying rooms at 58–62% RH and 16–21°C, avoiding light exposure, and minimizing handling will materially improve terpene retention. In practical terms, this is often the difference between a citrus-forward jar and one that smells generically grassy.

Experiential Effects and Onset

Users commonly report an upbeat, clear-headed onset with a gentle lift in motivation and mood. Onset is moderately quick—many notice initial effects within 3–7 minutes when inhaled, with peak around 20–30 minutes. The plateau tends to be steady rather than spiky, which is a key reason some patients prefer it during the day.

Duration by inhalation typically lasts 2–3 hours, aligning with many sativa-leaning hybrids and reflecting user reports seen with fast-onset cultivars like Sour Diesel selections. The comedown is clean, often with little residual grogginess. In higher doses, some users may experience a bright, focused intensity, so titration matters for sensitive individuals.

The mental effect is usually described as calm-alert rather than racy, with a modest anxiolytic ceiling when the dose is kept reasonable. Physically, a light body ease develops over the first hour, softening tension without heavy couchlock. Appetite enhancement is variable but present in a subset of users, similar to reports with appetite-stimulating strains like Zkittlez, though typically milder here.

Socially, the strain tends to be talkative and task-friendly, with many users citing better flow during creative or routine work. Compared to laughing, tingly hybrids such as Apple Fritter, Medi Bomb #2 is steadier and more linear in its mood lift. That predictability supports medical use cases that require functionality alongside relief.

Potential Medical Uses

Medi Bomb #2’s sativa-led, clear effect profile makes it a candidate for symptoms that benefit from alertness and mood support. Users commonly explore it for stress-related tension, mild-to-moderate depression, and fatigue-related focus dips. The combination of limonene and caryophyllene may contribute to perceived mood and inflammation support, though human evidence remains preliminary.

Patients with neuropathic discomfort and musculoskeletal strain often report partial relief without sedation, which can be crucial for daytime mobility. For inflammation-linked pain, balanced THC with caryophyllene-rich terpenes is frequently preferred over ultra-high-THC heavy indicas that impair function. In such scenarios, regular, smaller doses spread throughout the day may deliver steadier symptom control.

Some individuals report appetite normalization, though this effect is idiosyncratic and dose-dependent. For patients sensitive to anxiety with strong sativas, starting with low inhaled doses or oral microdoses (e.g., 1–2 mg THC) can reduce the risk of overstimulation. Titration advice often emphasizes slow step-ups with careful symptom tracking and attention to set and setting.

As with all cannabis-based interventions, personal variation is significant, and medical supervision is advisable, particularly when cannabis is combined with other medications. Batch-specific lab reports are invaluable—look for COAs that list cannabinoids and terpenes, and consider how different profiles influence your response. Many patients find that chemotype